- Home
- NODK vs SPRC Comparison
NODK vs SPRC Comparison
Compare NODK & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NODK
- SPRC
- Stock Information
- Founded
- NODK 1946
- SPRC 2004
- Country
- NODK United States
- SPRC Israel
- Employees
- NODK N/A
- SPRC N/A
- Industry
- NODK Property-Casualty Insurers
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- NODK Finance
- SPRC Health Care
- Exchange
- NODK Nasdaq
- SPRC Nasdaq
- Market Cap
- NODK 327.3M
- SPRC 2.5M
- IPO Year
- NODK 2017
- SPRC N/A
- Fundamental
- Price
- NODK $15.31
- SPRC $0.21
- Analyst Decision
- NODK
- SPRC
- Analyst Count
- NODK 0
- SPRC 0
- Target Price
- NODK N/A
- SPRC N/A
- AVG Volume (30 Days)
- NODK 26.8K
- SPRC 601.6K
- Earning Date
- NODK 11-07-2024
- SPRC 02-15-2025
- Dividend Yield
- NODK N/A
- SPRC N/A
- EPS Growth
- NODK N/A
- SPRC N/A
- EPS
- NODK N/A
- SPRC N/A
- Revenue
- NODK $391,655,000.00
- SPRC $1,747,000.00
- Revenue This Year
- NODK N/A
- SPRC N/A
- Revenue Next Year
- NODK N/A
- SPRC N/A
- P/E Ratio
- NODK N/A
- SPRC N/A
- Revenue Growth
- NODK 22.91
- SPRC N/A
- 52 Week Low
- NODK $12.71
- SPRC $0.20
- 52 Week High
- NODK $17.24
- SPRC $6.78
- Technical
- Relative Strength Index (RSI)
- NODK 36.09
- SPRC 43.06
- Support Level
- NODK $15.59
- SPRC $0.20
- Resistance Level
- NODK $16.90
- SPRC $0.24
- Average True Range (ATR)
- NODK 0.43
- SPRC 0.02
- MACD
- NODK -0.17
- SPRC -0.00
- Stochastic Oscillator
- NODK 3.02
- SPRC 14.64
About NODK NI Holdings Inc.
NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.